EBS
Price
$5.50
Change
+$0.12 (+2.23%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
120.07M
109 days until earnings call
OPTN
Price
$9.29
Change
+$0.03 (+0.32%)
Updated
Apr 25, 02:17 PM (EDT)
Capitalization
164.47M
Ad is loading...

EBS vs OPTN

Header iconEBS vs OPTN Comparison
Open Charts EBS vs OPTNBanner chart's image
Emergent Biosolutions
Price$5.50
Change+$0.12 (+2.23%)
Volume$2.84K
Capitalization120.07M
OptiNose
Price$9.29
Change+$0.03 (+0.32%)
Volume$186
Capitalization164.47M
EBS vs OPTN Comparison Chart
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. OPTN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a StrongBuy and OPTN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (EBS: $5.37 vs. OPTN: $9.26)
Brand notoriety: EBS and OPTN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EBS: 94% vs. OPTN: 40%
Market capitalization -- EBS: $120.07M vs. OPTN: $164.47M
EBS [@Pharmaceuticals: Other] is valued at $120.07M. OPTN’s [@Pharmaceuticals: Other] market capitalization is $164.47M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileOPTN’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • OPTN’s FA Score: 0 green, 5 red.
According to our system of comparison, OPTN is a better buy in the long-term than EBS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 3 TA indicator(s) are bullish while OPTN’s TA Score has 5 bullish TA indicator(s).

  • EBS’s TA Score: 3 bullish, 5 bearish.
  • OPTN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OPTN is a better buy in the short-term than EBS.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +16.23% price change this week, while OPTN (@Pharmaceuticals: Other) price change was +0.98% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was -9.80%.

Reported Earning Dates

EBS is expected to report earnings on Aug 12, 2025.

OPTN is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPTN($164M) has a higher market cap than EBS($120M). OPTN YTD gains are higher at: 38.623 vs. EBS (-43.828). OPTN has higher annual earnings (EBITDA): -15.55M vs. EBS (-518.2M). EBS has more cash in the bank: 112M vs. OPTN (73.7M). OPTN has less debt than EBS: OPTN (132M) vs EBS (860M). EBS has higher revenues than OPTN: EBS (1.02B) vs OPTN (71M).
EBSOPTNEBS / OPTN
Capitalization120M164M73%
EBITDA-518.2M-15.55M3,332%
Gain YTD-43.82838.623-113%
P/E Ratio17.73N/A-
Revenue1.02B71M1,441%
Total Cash112M73.7M152%
Total Debt860M132M652%
FUNDAMENTALS RATINGS
EBS vs OPTN: Fundamental Ratings
EBS
OPTN
OUTLOOK RATING
1..100
1215
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
6349
P/E GROWTH RATING
1..100
9100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPTN's Valuation (35) in the Medical Or Nursing Services industry is in the same range as EBS (57) in the Biotechnology industry. This means that OPTN’s stock grew similarly to EBS’s over the last 12 months.

OPTN's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as EBS (100) in the Biotechnology industry. This means that OPTN’s stock grew similarly to EBS’s over the last 12 months.

EBS's SMR Rating (94) in the Biotechnology industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that EBS’s stock grew similarly to OPTN’s over the last 12 months.

OPTN's Price Growth Rating (49) in the Medical Or Nursing Services industry is in the same range as EBS (63) in the Biotechnology industry. This means that OPTN’s stock grew similarly to EBS’s over the last 12 months.

EBS's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for OPTN (100) in the Medical Or Nursing Services industry. This means that EBS’s stock grew significantly faster than OPTN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSOPTN
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMRC0.750.09
+13.27%
Texas Mineral Resources Corp.
UOLGY17.810.31
+1.77%
UOL Group Ltd.
GLRBX21.56N/A
N/A
James Balanced: Golden Rainbow R
GTLLX24.28N/A
N/A
Glenmede Disciplined US Growth Eq Ptf
TRWAX21.80N/A
N/A
Transamerica International Equity A

OPTN and

Correlation & Price change

A.I.dvisor tells us that OPTN and RMTI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTN and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPTN
1D Price
Change %
OPTN100%
+0.87%
RMTI - OPTN
27%
Poorly correlated
+3.48%
EBS - OPTN
23%
Poorly correlated
+7.83%
NBIX - OPTN
22%
Poorly correlated
+2.46%
ANIP - OPTN
22%
Poorly correlated
+1.86%
AVDL - OPTN
21%
Poorly correlated
+3.49%
More